Skip to content
n:ews

Tag: Stryker

Health Company signal

Stryker Cuts Outlook as Cyberattack Impact on Supply Lingers

Stryker lowered its 2026 forecast, now expecting organic sales growth of 6.5% to 7% versus as much as 9.3% previously, and adjusted earnings of $14.80 to $14.90 a share. Third-quarter adjusted earnings of $3.52 a share on $6.5 billion of revenue missed estimates. The company said recovery from the March cyberattack is taking longer than expected, and hip and knee demand also slowed.